MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Clinical trials for MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could diabetes pills boost cancer immunotherapy?
Disease control Recruiting nowThis phase 2 trial is testing whether adding common diabetes drugs (metformin or rosiglitazone) to standard immunotherapy (nivolumab or pembrolizumab) can improve treatment for several advanced solid tumors, including melanoma, lung cancer, and liver cancer. About 72 participants…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC